Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

7.88
Delayed Data
As of Jul 31
 +0.07 / +0.90%
Today’s Change
2.97
Today|||52-Week Range
13.58
+83.26%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close7.81
Today’s open7.80
Day’s range7.70 - 8.09
Volume928,904
Average volume (3 months)706,021
Market cap$247.1M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-33.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales292.69
Price/Book18.92

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.75+4.57%
LNTHLantheus Holdings In...+0.10+1.38%
OXFDOxford Immunotec Glo...+0.19+1.45%
VCYTVeracyte Inc+0.47+4.22%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts